Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting

To identify molecular markers indicative of response to tamoxifen and easily implemented in the routine setting, we recently reported three gene signatures that could stratify post‐menopausal tamoxifen‐treated, estrogen receptor‐positive (ER+) patients according to outcome in the adjuvant setting. H...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Oncol
Asıl Yazarlar: Sieuwerts, Anieta M., Lyng, Maria B., Meijer-van Gelder, Marion E., de Weerd, Vanja, Sweep, Fred C.G.J., Foekens, John A., Span, Paul N., Martens, John W.M., Ditzel, Henrik J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2014
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528606/
https://ncbi.nlm.nih.gov/pubmed/25081647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller